NEW YORK (GenomeWeb News) – Molecular diagnostics firm Transplant Genomics has raised $2.8 million toward a targeted $3 million in a private offering, the company said in a document filed with the US Securities and Exchange Commission on Friday.

The firm declined to identify the investors in the round, but a spokesperson said that the funds will be used to commercialize its first product, a test for improving the management of kidney transplant recipients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.